Multiple Sclerosis: Is Therapeutic Angiogenesis a Treatment or Even a Possible Cure?
18 nov. 2020 00h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announced that it will give a Webinar broadcast on its potential breakthrough therapy to...
Zhittya Genesis Medicine Announces It Has Been Approved to Initiate Clinical Trials in Mexico for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
15 oct. 2020 10h30 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announces that it will initiate clinical trials in Mexico to test a medical hypothesis that...
Zhittya Genesis Medicine Announces a Potential Major Medical Breakthrough for the Treatment of Parkinson’s Disease
22 sept. 2020 10h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announces that it will initiate clinical trials to test a medical hypothesis that has been...
Zhittya Genesis Medicine, Inc. Announces a Zoom Webinar
22 juil. 2020 10h30 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, July 22, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (Zhittya), a private company, announced that it will give a Zoom Webinar on its potential breakthrough therapy to reverse...
COVID-19 Lung Damage: Potential Breakthrough Drug Treatment Disclosed by Zhittya Genesis Medicine in Their Newly Released White Paper
17 juin 2020 10h30 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, June 17, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company)(“Zhittya” or the “Company”), announced that its latest White Paper, which details results on its...
Zhittya Genesis Medicine Releases Latest White Paper Highlighting its Potential Breakthrough Drug Treatment for Chronic Depression
19 févr. 2020 12h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), announced that its latest White Paper, which details results on its...
Zhittya Genesis Medicine Obtains Regulatory Approval in Mexico to Start Phase I Clinical Trials in Patients with Parkinson’s Disease
13 févr. 2020 12h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), announced that it has received official regulatory approval from...
Zhittya Genesis Medicine Signs $151.5 Million Biopharmaceutical Marketing Partnership Agreement with Regenerative Medicine of Latin America
22 janv. 2020 12h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Jan. 22, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), has signed a $151.5 million USD international marketing partnership...
Zhittya Genesis Medicine Releases White Paper Detailing a Potential Breakthrough Treatment for Parkinson’s Disease
15 janv. 2020 12h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), announced that its White Paper, which details results on its...
Zhittya Genesis Medicine Signs $150 Million Biopharmaceutical Marketing Partnership Agreement with Regenerative Medicine of China
09 janv. 2020 12h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), has signed a $150 million USD international marketing partnership...